Objective. Intradiscal biacuplasty (IDB) is a novel bipolar cooled radiofrequency system for the treatment of degenerative disk disease. We present the results of a pilot trial with 6-month follow-up.
Introduction

I
ntervertebral discogenic pain is a major source of lower back pain [1] and remains difficult to treat. Conservative management has not been associated with therapeutic successes and other treatment modalities such as spinal fusion and disc replacement procedures remain controversial [2, 3] . The use of intervertebral disc heating procedures such as intradiscal electrothermal therapy (IDET) has been shown to benefit a small group of properly selected patients [4, 5, 6] . Patients not likely to benefit from IDET include those with multilevel degenerative disc disease [5] , overweight patients [7] , and patients receiving Workers Compensation benefits [6, 8] . Other reasons for poor outcome following the use of the IDET heating technique to treat discogenic pain can be attributed to the difficulty in navigating the catheter reproducibly and the lack of reproducible uniform thermal lesion. Bogduk et al. have argued, for example, that temperatures produced by the SpineCath catheter (Smith and Nephew plc, London, UK) used in IDET procedures may be insufficient to generate effective lesions [9] .
Intradiscal biacuplasty (IDB) using the TransDiscal system (Baylis Medical Inc., Montreal, Canada) is approved for clinical use by the FDA. The system uses bipolar radiofrequency electrodes placed obliquely on the posterolateral aspects of the intervertebral annulus. This system appears to produce precise thermal profiles within the posterior annulus [10] . IDB differs from the IDET annuloplasty in that a long, flexible heating coil catheter is unnecessary and potential difficulty in navigating a flexible device against or in between the lamellae of the posterior annular wall is negated. The TransDiscal electrodes are placed without the need for steering. Presumably, this reduces placement difficulties and leads to reproducible uniform lesions. We thus conducted a pilot study on 15 patients suffering from chronic lumbar discogenic pain to evaluate their pain relief and functional capacity improvement.
Methods
After approval from the Cleveland Clinic Institutional Review Board, written informed consent was obtained from 15 patients who were previously denied minimally invasive intradiscal annuloplasty (IDET) by their health insurance companies. All had received magnetic resonance imaging (MRI) and provocative discography of the lumbar spine in the previous year.
Inclusion criteria adopted for these studies were as follows: history of chronic low back pain unresponsive to nonoperative care for a period longer than 6 months, back pain greater than the leg pain that is commonly exacerbated by sitting, concordant pain reproduced on provocative discography in degenerated, but not in control discs, disc height of at least 50% of the adjacent control disc [4, 11, 12] , single-level degenerative disc disease or two-level disease without evidence of additional degenerative changes in other disc spaces on MRI.
The exclusion criteria were: evidence of compressive radiculopathy, nucleus pulposus herniation on the MRI, disc bulges exceeding 5 mm, prior surgery at the symptomatic level, symptoms or signs of lumbar canal stenosis, pending Workers Compensation claim or litigation [6, 8] , psychological issues by examination or history, score >16 on Beck Depression Inventory, tumor, systemic infection or localized infection at the anticipated entry needle sites, traumatic spinal fracture, history of coagulopathy, unexplained bleeding, progressive neurological deficits, history of opioid abuse or current use of long-acting opioids, presence of free disc fragments on MRI, manual labor, smoking, body mass index >30, and age >55 years [4, 6] .
Intradiscal biacuplasty was performed on an outpatient basis with fluoroscopic guidance. Intravenous access was obtained and five-lead electrocardiogram, continuous pulse oximetry, and noninvasive blood pressure monitors were placed. Prophylactic intravenous antibiotics were administered 15-40 minutes prior to beginning the procedure. Patients were positioned prone and given 1-4 mg of intravenous midazolam and 0-100 mg of intravenous fentanyl before and during the procedure, as necessary. Two TransDiscal probes (Baylis Medical Inc.) were positioned in the posterolateral aspect of the annulus of the relevant disc using an oblique approach (Figure 1 ). To facilitate accurate placement, two electrically insulated 17 g TransDiscal introducers were used to gain access to the intervertebral disc space. TransDiscal radiofrequency probes were then be positioned within each of the introducers bilaterally to create a bipolar treatment configuration. Probe placement within the disc annulus was confirmed using oblique, lateral, and anterior-posterior fluoroscopy ( Figures 2-4) .
Tissue heating was initiated through a programmed gradual temperature ramp to 55°C over 11 minutes. This temperature was then maintained for an additional 4 minutes to complete the treatment program. Throughout, patients were awake and able to communicate. When the procedure was complete, patients were transferred to a recovery area and monitored for 45 minutes prior to discharge with postprocedural instructions and a stabilizing brace to be worn only when awake around the abdomen. Patients were also prescribed a physical therapy regimen previously established for patients undergoing treatment for similar procedures [4] [5] [6] .
Baseline values were obtained before procedure and patients were subsequently monitored for outcomes at follow-up visits scheduled at 1, 3, and 6 months after the procedure. On each occasion, pain disability data were collected using Oswestry (50 points scale) and Short Form (SF)-36 questionnaires, visual analog scale (VAS) pain scores, and opioid use. Opioids were converted to morphine sulfate equivalents. To asses for possible complications follow-up visits were conducted after each periodic questionnaire completion.
Statistical Analysis
For the Oswestry score, SF-36 Physical Functionality (PF) score, and the SF-36 Bodily Pain (BP) score, which were normally distributed at each time point, we used a repeated measures analysis of variance that adjusts the standard errors of the means at each time point based on the withinpatient correlation. The overall time effect was tested using an F-test, while pair-wise comparisons of means were made using Tukey's honest significant difference adjustment for controlling experiment-wide error rate.
For the non-normally distributed endpoints (VAS pain score and opioid use) we used the Wilcoxon signed rank test of location difference between time points and Friedman's chi-square test for ranks for the overall test. A Bonferroni adjustment to the significance criterion was used for multiple comparisons.
The experiment-wide error rate for all tests was controlled at a significance level of 5%. Results are presented as mean (SD), median [quartiles] or mean (confidence interval [CI] ). SAS version 9.1 software (SAS Institute, Cary, NC, USA) and R version 2.3.1 software (The R Foundation for Statistical Computing) were used for all statistical analysis and graphics.
Results
Patients enrolled in the study ranged from 22 to 55 years old; there were eight women and seven men. Demographic characteristics and details about the patients' back pain are shown in Table 1 . Body mass index ranged from 18.3 to 30.3 kg/m 2 , with mean (SD) of 26.7 (5.9). All but two were employed: one woman was a homemaker and one man was retired. Only one patient was previously employed as a light manual laborer. One had a recent history of smoking but quit approximately 1 year previously. Beck Depression Inventory scores ranged from 1 to 13. Among the 15 patients enrolled, 13 remained in follow-up at 6 months; one other withdrew voluntarily and one was removed because she failed to disclose ongoing litigation directly related to her back pain.
Visual analog scale, SF-36, and opioid use are summarized in Table 2 (actual values), Table 3 (changes among time points), and Table 4 (P values for changes). VAS pain score decreased from baseline to the first follow-up visit at 30 days a median (95% CI) change of 3 cm (2, 7). Additionally, at first follow-up visit, Oswestry scores were significantly reduced by an average (95% CI) of 6.8 points (3.1, 10.6). For these two variables, statistically significant differences from baseline were also observed at 3 and 6 months.
Short Form-36 PF scores, SF-36 BP scores, and opioid use did not change significantly from baseline to 1 month. Changes from baseline were statistically significant at 3 months and thereafter, however, for SF-36 PF and SF-36 BP scores. At 3 months, SF-36 PF scores improved an average (95% CI) of 14.9 points (6.3, 23.5) and SF-36 BP scores improved by 13.7 points (3.6, 23.8). Opioid use did not significantly change through the course of the study. Neither was there any statistically significant difference among the follow-up times themselves (between 1, 3, and 6 months) for any of the outcomes. Seven out of 13 patients followed over 6 months had more than 50% improvements in their pain scores. There were no patients with worse pain scores 6 months after procedure. One patient is considering spine fusion surgery.
Discussion
Pain scores and functional capacity improved in most of our patients, and the results are somewhat better [4] or similar [5] to the outcomes previously reported with IDET in similar patient groups (Tables 2-4 ). Based on improved functional capacity, decreased pain scores, and reduced opioid use, our results suggest that IDB using the TransDiscal system may be an effective minimally invasive procedure for the treatment of chronic discogenic back pain in properly selected patients ( Figure 5 and Table 2 ).
An advantage of the TransDiscal system over previously available procedures is the ease by which bipolar electrodes can be positioned directly in posterior annulus (Figure 1 ). This eliminates the difficulties inherent in threading a long, flexible heating coil catheter, over the region of the posterolateral disc where radial fissures are frequently present.
We have previously described histopathological evaluation of the posterior annulus in cadaver tissues subject to IDB using the TransDiscal system, which indicated the absence of nerve root or surrounding tissue damage [10] . As might thus be expected, none of our patients demonstrated an increase in pain, new-onset pain, or neurological deficit. These positive results may be attributable to the radiofrequency electrode cooling technology used by the TransDiscal system, which allows a large volume of tissue to be heated while avoiding excessive heating close to the electrodes. The selection of patients for enrollment in this study was similar to that used in previous large studies evaluating IDET systems [4, 5, 11, 12] . Selection was stringent and included only a small fraction of the population typically presenting at a spine or interventional pain management clinic with discogenic pain. But these patients seem especially likely to benefit from avoiding far more invasive surgical solutions such as lumbar fusion surgery or disc arthroplasty. IDB might thus benefit their quality of life, at very least because recovery duration is shorter after a minimally invasive, percutaneous outpatient procedure.
Previous clinical experience of posterior annulus thermal treatment for discogenic pain using IDET has suggested that improvements recorded at 6 months post treatment are maintained throughout the first and second year after annuloplasty [4, 5, 11, 12] . It remains unknown, though, whether the improvements we observed at 6 months will be maintained.
The major limitations of our study are that only 15 patients were evaluated, that a contemporaneous control group was not included, and that neither patients nor the investigators conducting follow-up assessments were blinded to treatment. Therefore, the observed changes cannot be attributed solely to the intervention. Our results should thus be considered preliminary rather than definitive. They do suggest, though, that an adequately powered, randomized, and blinded trial would be worth conducting.
In summary, patients having IDB using the TransDiscal system demonstrated substantial and statistically significant improvements in pain (years)  22  41  44  55  28  55  46  33  35  31  49  48  26  23  52  Years of back pain  6  3  10  20  6  7  1  1  6  3  11  5  2  3  4  Degenerated lumbar discs  on MRI (number)   2  2  1  2  2  2  1  1  2  1  2  2  2  2  2 Discography positive lumbar discs (number) Opioid use Baseline  -40  70  180  40  -160  40  160  40  20  120  40  5  40  1 months  -0  70  180  0  -160  40  80  0  0  120  40  5  40  3 months  -20  40  180  0  -0  40  60  0  0  160  40  5  40  6 scores and functional capacity ( Figure 5 and Table 2 -4). Improvement was apparent at the first follow-up visit at 1 month, and persisted throughout 6 months of observation. The observed decrease in opioid use was not statistically significant. IDB might be an effective minimally invasive procedure for the treatment of intervertebral discogenic pain. 
